Risk factors
Harrow (HROW) risk factors
Item 1A of every Harrow, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors53 risks6 new8 dropped8 reworded
Harrow refinanced its debt by issuing $250 million of 8.625% Senior Notes due 2030 and repaying prior loans including the Oaktree Loan. Accumulated deficit increased to $156,524,000 as of December 31, 2025. Regulatory compliance risks expanded to include specific FDA Form 483 observations from a 2024 inspection of NJOF.
Filed Mar 02, 2026 - FY2024 10-K risk factors55 risks
Harrow faces heavy risks regarding future profitability, reliant on FDA-approved products, compounding facilities, and complex third-party payor reimbursement.
Filed Mar 27, 2025